These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 786281)

  • 21. Comparative experimental evaluation of immunodepressive and toxic effects of L-asparaginase (NSC-109229) from Escherichia coli and from Erwinia carotovora.
    Cavanna M; Celle G; Dodero M; Picciotto A; Pannacciulli I; Brambilla G
    Cancer Treat Rep; 1976 Mar; 60(3):255-7. PubMed ID: 769978
    [No Abstract]   [Full Text] [Related]  

  • 22. Therapy with Erwinia L-asparaginase in children with acute leukemia after anaphylaxis to E. coli L-asparaginase.
    King OY; Wilbur JR; Mumford DM; Sutow WW
    Cancer; 1974 Mar; 33(3):611-4. PubMed ID: 4592901
    [No Abstract]   [Full Text] [Related]  

  • 23. An enzymatic method for the kinetic measurement of L-asparaginase activity and L-asparagine with an ammonia gas-sensing electrode.
    Tagami S; Matsuda K
    Chem Pharm Bull (Tokyo); 1990 Jan; 38(1):153-5. PubMed ID: 2186873
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A facile enzymatic method for the location of radioactivity associated with the carbons of L-aspartic acid, L-asparagine, and beta-cyano-L-alanine.
    Cooney DA; Jayaram HN
    Anal Biochem; 1978 Sep; 89(2):508-20. PubMed ID: 365017
    [No Abstract]   [Full Text] [Related]  

  • 25. Analytical validation of a microplate reader-based method for the therapeutic drug monitoring of L-asparaginase in human serum.
    Lanvers C; Vieira Pinheiro JP; Hempel G; Wuerthwein G; Boos J
    Anal Biochem; 2002 Oct; 309(1):117-26. PubMed ID: 12381370
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Relationship between the magnitude of Km and pH for L-asparaginase].
    Libinson GS; Mikhalev AV
    Biokhimiia; 1976 Jan; 41(1):149-52. PubMed ID: 6070
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Minimal effects of E. coli and Erwinia asparaginase on the coagulation system in childhood acute lymphoblastic leukemia: a randomized study.
    Risseeuw-Appel IM; Dekker I; Hop WC; Hählen K
    Med Pediatr Oncol; 1994; 23(4):335-43. PubMed ID: 8058004
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Results of an experimental study of the antitumor activity of 1-asparaginase from E. coli and Erw. carotovora].
    Terent'eva TG; Sokolov AB; Navashin SM
    Antibiotiki; 1977 Jan; 22(1):78-81. PubMed ID: 320935
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Minimal residual disease (MRD) measurement as a tool to compare the efficacy of chemotherapeutic drug regimens using Escherichia Coli-asparaginase or Erwinia-asparaginase in childhood acute lymphoblastic leukemia (ALL).
    Kwok CS; Kham SK; Ariffin H; Lin HP; Quah TC; Yeoh AE
    Pediatr Blood Cancer; 2006 Sep; 47(3):299-304. PubMed ID: 16302217
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Toxic and immunodepressive effects of L-asparaginase from E. coli and from Erwinia carotovora following chronic administration in rats.
    Celle G; Dodero M; Cuneo P; Picciotto A; Brambilla G; Cavanna M; Pannaciulli I
    Arzneimittelforschung; 1977; 27(11):2046-50. PubMed ID: 341899
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Asparaginase and glutaminase activities of bacteria.
    Wade HE; Robinson HK; Phillips BW
    J Gen Microbiol; 1971 Dec; 69(3):299-312. PubMed ID: 5004160
    [No Abstract]   [Full Text] [Related]  

  • 32. Kinetic analysis of hepatotoxicity associated with antineoplastic asparaginases.
    Durden DL; Salazar AM; Distasio JA
    Cancer Res; 1983 Apr; 43(4):1602-5. PubMed ID: 6339039
    [No Abstract]   [Full Text] [Related]  

  • 33. Effect of glucocorticoids, E. coli- and Erwinia L-asparaginase on hemostatic proteins in children with acute lymphoblastic leukemia.
    Mall V; Thomas KB; Sauter S; Niemeyer CM; Sutor AH
    Klin Padiatr; 1999; 211(4):205-10. PubMed ID: 10472551
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical experience with L-asparaginase.
    Hamilton-Fairley G; Malpas JS; Galton DA
    Recent Results Cancer Res; 1970; 33():257-62. PubMed ID: 4949164
    [No Abstract]   [Full Text] [Related]  

  • 35. Cloning and expression of the Erwinia chrysanthemi asparaginase gene in Escherichia coli and Erwinia carotovora.
    Gilbert HJ; Blazek R; Bullman HM; Minton NP
    J Gen Microbiol; 1986 Jan; 132(1):151-60. PubMed ID: 3011958
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Attenuation of asparaginase-induced hyperglycemia after substitution of the Erwinia carotovora for the Escherichia coli enzyme preparation.
    Ridgway D; Neerhout RC; Bleyer A
    Cancer; 1989 Feb; 63(3):561-3. PubMed ID: 2643458
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [L-asparaginases from Escherichia coli. II. Plurality and origin of molecular forms. Relations with the biological activity].
    Laboureur P; Langlois C; Labrousse M; Boudon M; Emeraud J; Samain JF; Ageron M; Dumesnil Y
    Biochimie; 1971; 53(11):1157-65. PubMed ID: 4948671
    [No Abstract]   [Full Text] [Related]  

  • 38. Asparaginase: molecular and enzymic requirements for use as an antileukaemia agent.
    Wade HE
    J Gen Microbiol; 1971 Mar; 65(3):x-xi. PubMed ID: 4997395
    [No Abstract]   [Full Text] [Related]  

  • 39. Therapeutic drug monitoring of asparaginase in the ALL-BFM 2000 protocol between 2000 and 2007.
    Schrey D; Borghorst S; Lanvers-Kaminsky C; Hempel G; Gerss J; Möricke A; Schrappe M; Boos J
    Pediatr Blood Cancer; 2010 Jul; 54(7):952-8. PubMed ID: 20108339
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Thin-layer chromatographic determination of L-asparaginase in the presence of human serum.
    Pahuja SL; Reid TW
    J Chromatogr; 1983 Apr; 273(2):431-5. PubMed ID: 6345564
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.